Shopping Cart 0
Cart Subtotal
AED 0

Personal Genome Diagnostics Inc - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 8258
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories. PGD offers high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides custom solutions such as cancer whole genome analysis, cancer genome germline analysis, sample preparation and sequencing, data interpretation and analysis, cancer bioinformatic analysis and ctDNA analyses, among others. The company caters to academics, biotechnology and pharmaceutical companies, and contract research organizations. PGD is headquartered in Baltimore, Maryland, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Personal Genome Diagnostics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Personal Genome Diagnostics Inc Company Overview 4

Personal Genome Diagnostics Inc Company Snapshot 4

Personal Genome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Personal Genome Diagnostics Inc-Pipeline Analysis Overview 6

Personal Genome Diagnostics Inc-Key Facts 6

Personal Genome Diagnostics Inc-Major Products and Services 7

Personal Genome Diagnostics Inc Pipeline Products by Development Stage 8

Personal Genome Diagnostics Inc Pipeline Products Overview 9

MutatorDETECT Assay 9

MutatorDETECT Assay Product Overview 9

PGDx Plasma Based Diagnostic Kit 10

PGDx Plasma Based Diagnostic Kit Product Overview 10

PGDx Tissue Based Diagnostic Kit 11

PGDx Tissue Based Diagnostic Kit Product Overview 11

PlasmaSelect-R Liquid Biopsy Test-CLIA 12

PlasmaSelect-R Liquid Biopsy Test-CLIA Product Overview 12

Personal Genome Diagnostics Inc-Key Competitors 13

Personal Genome Diagnostics Inc-Key Employees 14

Personal Genome Diagnostics Inc-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Personal Genome Diagnostics Inc, Recent Developments 16

Apr 19, 2018: Personal Genome Diagnostics TMB Analysis Used in Groundbreaking NEJM Study Showing Promising Checkpoint Inhibitor Efficacy in Early Stage Lung Cancer 16

Dec 14, 2017: Liquid Biopsy Results Differed Substantially Between Two Providers 16

Nov 10, 2017: U.S. Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract with Personal Genome Diagnostics 17

Jun 14, 2017: Personal Genome Diagnostics Awarded Department of Veterans Affairs Contract for Its PlasmaSELECT Liquid Biopsy Cancer Profiling Assay 18

Jun 02, 2017: Personal Genome Diagnostics Highlights its Patent-Pending Microsatellite Instability Testing Technology as FDA Approves Keytruda for MSI Tumors 18

Mar 30, 2017: Personal Genome Diagnostics Announces AACR Annual Meeting 2017 Presentations and Awards 19

Mar 28, 2017: Personal Genome Diagnostics' Expanded PlasmaSELECT 64 Is First Liquid Biopsy Pan-Cancer Profiling Panel to Include MSI Analyses for Immuno-Oncology 20

Mar 22, 2017: Personal Genome Diagnostics Announces Expanded Cancer Testing Contract with U.S. Department of Veteran Affairs 21

Feb 01, 2017: Personal Genome Diagnostics Awarded National Cancer Institute Contract to Develop Novel Diagnostic for Immuno-Oncology Drugs 21

Jan 17, 2017: Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development 22

Appendix 24

Methodology 24

About GlobalData 26

Contact Us 26

Disclaimer 27


List Of Figure

List of Figures

Personal Genome Diagnostics Inc Pipeline Products by Equipment Type 5

Personal Genome Diagnostics Inc Pipeline Products by Development Stage 8


List Of Table

List of Tables

Personal Genome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Personal Genome Diagnostics Inc Pipeline Products by Equipment Type 5

Personal Genome Diagnostics Inc Pipeline Products by Indication 5

Personal Genome Diagnostics Inc, Key Facts 6

Personal Genome Diagnostics Inc, Major Products and Services 7

Personal Genome Diagnostics Inc Number of Pipeline Products by Development Stage 8

Personal Genome Diagnostics Inc Pipeline Products Summary by Development Stage 8

MutatorDETECT Assay-Product Status 9

MutatorDETECT Assay-Product Description 9

PGDx Plasma Based Diagnostic Kit-Product Status 10

PGDx Plasma Based Diagnostic Kit-Product Description 10

PGDx Tissue Based Diagnostic Kit-Product Status 11

PGDx Tissue Based Diagnostic Kit-Product Description 11

PlasmaSelect-R Liquid Biopsy Test-CLIA-Product Status 12

PlasmaSelect-R Liquid Biopsy Test-CLIA-Product Description 12

Personal Genome Diagnostics Inc, Key Employees 14

Glossary 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Personal Genome Diagnostics Inc,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Adverum Biotechnologies Inc

Integrated Genomics, Inc.

Complete Genomics Inc

Summary

Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories. PGD offers high-throughput next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides custom solutions such as cancer whole genome analysis, cancer genome germline analysis, sample preparation and sequencing, data interpretation and analysis, cancer bioinformatic analysis and ctDNA analyses, among others. The company caters to academics, biotechnology and pharmaceutical companies, and contract research organizations. PGD is headquartered in Baltimore, Maryland, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Personal Genome Diagnostics Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Personal Genome Diagnostics Inc Company Overview 4

Personal Genome Diagnostics Inc Company Snapshot 4

Personal Genome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Personal Genome Diagnostics Inc-Pipeline Analysis Overview 6

Personal Genome Diagnostics Inc-Key Facts 6

Personal Genome Diagnostics Inc-Major Products and Services 7

Personal Genome Diagnostics Inc Pipeline Products by Development Stage 8

Personal Genome Diagnostics Inc Pipeline Products Overview 9

MutatorDETECT Assay 9

MutatorDETECT Assay Product Overview 9

PGDx Plasma Based Diagnostic Kit 10

PGDx Plasma Based Diagnostic Kit Product Overview 10

PGDx Tissue Based Diagnostic Kit 11

PGDx Tissue Based Diagnostic Kit Product Overview 11

PlasmaSelect-R Liquid Biopsy Test-CLIA 12

PlasmaSelect-R Liquid Biopsy Test-CLIA Product Overview 12

Personal Genome Diagnostics Inc-Key Competitors 13

Personal Genome Diagnostics Inc-Key Employees 14

Personal Genome Diagnostics Inc-Locations And Subsidiaries 15

Head Office 15

Recent Developments 16

Personal Genome Diagnostics Inc, Recent Developments 16

Apr 19, 2018: Personal Genome Diagnostics TMB Analysis Used in Groundbreaking NEJM Study Showing Promising Checkpoint Inhibitor Efficacy in Early Stage Lung Cancer 16

Dec 14, 2017: Liquid Biopsy Results Differed Substantially Between Two Providers 16

Nov 10, 2017: U.S. Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract with Personal Genome Diagnostics 17

Jun 14, 2017: Personal Genome Diagnostics Awarded Department of Veterans Affairs Contract for Its PlasmaSELECT Liquid Biopsy Cancer Profiling Assay 18

Jun 02, 2017: Personal Genome Diagnostics Highlights its Patent-Pending Microsatellite Instability Testing Technology as FDA Approves Keytruda for MSI Tumors 18

Mar 30, 2017: Personal Genome Diagnostics Announces AACR Annual Meeting 2017 Presentations and Awards 19

Mar 28, 2017: Personal Genome Diagnostics' Expanded PlasmaSELECT 64 Is First Liquid Biopsy Pan-Cancer Profiling Panel to Include MSI Analyses for Immuno-Oncology 20

Mar 22, 2017: Personal Genome Diagnostics Announces Expanded Cancer Testing Contract with U.S. Department of Veteran Affairs 21

Feb 01, 2017: Personal Genome Diagnostics Awarded National Cancer Institute Contract to Develop Novel Diagnostic for Immuno-Oncology Drugs 21

Jan 17, 2017: Personal Genome Diagnostics Adds James Lewis as Senior Vice President of Corporate Development 22

Appendix 24

Methodology 24

About GlobalData 26

Contact Us 26

Disclaimer 27


List Of Figure

List of Figures

Personal Genome Diagnostics Inc Pipeline Products by Equipment Type 5

Personal Genome Diagnostics Inc Pipeline Products by Development Stage 8


List Of Table

List of Tables

Personal Genome Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Personal Genome Diagnostics Inc Pipeline Products by Equipment Type 5

Personal Genome Diagnostics Inc Pipeline Products by Indication 5

Personal Genome Diagnostics Inc, Key Facts 6

Personal Genome Diagnostics Inc, Major Products and Services 7

Personal Genome Diagnostics Inc Number of Pipeline Products by Development Stage 8

Personal Genome Diagnostics Inc Pipeline Products Summary by Development Stage 8

MutatorDETECT Assay-Product Status 9

MutatorDETECT Assay-Product Description 9

PGDx Plasma Based Diagnostic Kit-Product Status 10

PGDx Plasma Based Diagnostic Kit-Product Description 10

PGDx Tissue Based Diagnostic Kit-Product Status 11

PGDx Tissue Based Diagnostic Kit-Product Description 11

PlasmaSelect-R Liquid Biopsy Test-CLIA-Product Status 12

PlasmaSelect-R Liquid Biopsy Test-CLIA-Product Description 12

Personal Genome Diagnostics Inc, Key Employees 14

Glossary 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Personal Genome Diagnostics Inc,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Adverum Biotechnologies Inc

Integrated Genomics, Inc.

Complete Genomics Inc